Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus

Myke D Federman1, Robert Kelly, Rick E Harrison

  • 1Division of Pediatric Critical Care, Department of Pediatrics, Mattel Children's Hospital UCLA, 10833 Le Conte Ave., Los Angeles, CA 90095, USA. mfederman@mednet.ucla.edu

Insights

Continuous intravenous midazolam infusion for pediatric status epilepticus can cause severe metabolic acidosis. Healthcare providers should carefully monitor children receiving high-dose midazolam infusions.

Area of Science:

  • Pediatric critical care medicine
  • Neuropharmacology

Background:

  • Midazolam is generally safe and effective for pediatric status epilepticus.
  • Continuous intravenous infusions of midazolam show encouraging efficacy in pediatric patients.

Observation:

  • A 9-year-old girl with refractory status epilepticus received high-dose, continuous intravenous midazolam.
  • The patient developed severe hyperchloremic metabolic acidosis and hemodynamic compromise.

Findings:

  • The complication is suspected to be due to hydrochloric acid in the midazolam preparation.
  • Metabolic acidosis resolved within 5 hours of stopping the midazolam infusion.
  • Inotropic and vasopressor support was weaned after midazolam discontinuation.

Implications:

  • Caution is advised when administering continuous intravenous midazolam infusions to pediatric patients.
  • Close clinical and laboratory monitoring is essential for pediatric patients receiving high-dose midazolam.
  • This complication highlights potential risks associated with parenteral midazolam preparation.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...